The Frederick National Laboratory for Cancer Research works at the forefront of basic, translational, and clinical science with a focus on cancer, AIDS, and infectious disease.
SeroNet is a collaboration of 25 biomedical research institutions that work to give a deeper understanding to the immune response of the novel coronavirus, SARS-CoV-2. This effort provides leadership, expertise, and coordination to the National Cancer Institute initiative.
The Nanotechnology Characterization Laboratory is a national resource that reviews nanotechnologies intended for cancer therapies and diagnostics.
The National Cryo-Electron Microscopy Facility offers cancer researchers access to technology and expertise to advance their work through high-resolution cryo-EM studies.
What We Do
Coming Events
Careers
Whether you’re an expert in your field or just starting out, we have a career opportunity for you. We’re always looking for people to join us in fulfilling the mission of the Frederick National Laboratory: discovery, innovation, and success in the biomedical sciences.
Our team of 2,400+ scientists, technicians, administrators, and support staff work at the forefront of basic, translational, and preclinical science, with a focus on cancer, AIDS and other infectious diseases.
Business Opportunities
Subcontracting and outsourcing are crucial for the operation of the Frederick National Laboratory on behalf of our customers, both locally and globally. Our solicitations for vendors and subcontractors include support in research services, facility infrastructure, laboratory supplies, supply chain operations, and other operational needs.
FNL by the Numbers
170
unique biopharmaceuticals developed
150
genetically engineered cancer models
450
nanoparticles characterized
187
distinct partnershipsFrederick National Laboratory on Twitter
Are you interested in how #datascience could progress #cancerresearch? Be sure to register for the Computational Approaches for Cancer Workshop, happening alongside @Supercomputing on Nov. 14. https://t.co/QuKOEoZmXJ https://t.co/dekaqLgrQt
Interested in #AI in drug discovery? Register for @theNCI virtual workshop on Rational Drug Discovery, October 18-19, 10am–5 pm ET. Topics include key developments in structural biology, chemical biology and novel modalities: https://t.co/8Kun5r6n57 https://t.co/z797jfA1Q6
Join today (10/15) at 10 am EST for the first lecture in our latest Scientific Partners Distinguished Lecture Series with @Georgetown. Click here for the WebEx link: https://t.co/3ysOCpgLPN https://t.co/y9qLIvQ08d
